AWAG
ABBV icon

ARS Wealth Advisors Group’s AbbVie ABBV Stock Holding History

ARS Wealth Advisors Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.35M Buy
9,349
+1,604
+21% +$345K 0.18% 63
2026
Q1 		$1.68M Buy
7,745
+5
+0.1% +$1.11K 0.14% 69
2025
Q4 		$1.77M Buy
7,740
+2
+0% +$456 0.16% 61
2025
Q3 		$1.79M Buy
7,738
+285
+4% +$58K 0.18% 60
2025
Q2 		$1.38M Buy
7,453
+202
+3% +$37.5K 0.16% 64
2025
Q1 		$1.52M Sell
7,251
-22
-0.3% -$4.28K 0.21% 54
2024
Q4 		$1.29M Buy
7,273
+905
+14% +$166K 0.18% 56
2024
Q3 		$1.26M Buy
6,368
+261
+4% +$48.7K 0.15% 60
2024
Q2 		$1.05M Buy
6,107
+568
+10% +$94.1K 0.14% 65
2024
Q1 		$1.01M Sell
5,539
-192
-3% -$33.1K 0.14% 67
2023
Q4 		$888K Sell
5,731
-3,619
-39% -$528K 0.13% 69
2023
Q3 		$1.39M Buy
9,350
+3,819
+69% +$561K 0.23% 56
2023
Q2 		$745K Buy
5,531
+1,466
+36% +$215K 0.12% 78
2023
Q1 		$648K Sell
4,065
-26
-0.6% -$3.98K 0.12% 73
2022
Q4 		$661K Sell
4,091
-95
-2% -$14.6K 0.11% 77
2022
Q3 		$562K Buy
4,186
+1
+0% +$143 0.09% 90
2022
Q2 		$641K Sell
4,185
-208
-5% -$31.8K 0.09% 94
2022
Q1 		$712K Sell
4,393
-324
-7% -$47.1K 0.12% 64
2021
Q4 		$639K Buy
4,717
+25
+0.5% +$2.95K 0.11% 76
2021
Q3 		$506K Buy
+4,692
New +$536K 0.09% 79

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

ARS Wealth Advisors Group's ABBV Position: Q2 2026 in Review

ARS Wealth Advisors Group increased its AbbVie (ABBV) stake by 21% in Q2 2026, buying an estimated $345K and bringing the position to 9,349 shares worth $2.35M. The position accounts for 0.18% of the portfolio, ranked #63.

ARS Wealth Advisors Group first reported a position in ABBV in Q3 2021 and has held it in 20 quarters since. 1,797 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • ARS Wealth Advisors Group held 9,349 shares of AbbVie worth $2.35M as of Q2 2026.
  • ARS Wealth Advisors Group bought 1,604 AbbVie shares in Q2 2026, an estimated $345K.
  • AbbVie made up 0.18% of ARS Wealth Advisors Group's portfolio in Q2 2026, its #63 holding.
  • ARS Wealth Advisors Group first reported a position in AbbVie in Q3 2021 and has held it in 20 quarters since.
  • 1,797 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on ARS Wealth Advisors Group's 13F filing for Q2 2026, filed 16 Jul 2026.